Stockreport

Genmab A/S (GMAB) Shares Gain Analyst Support as Deutsche Bank Sees Oncology Upside [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF TheFly reported on January 8 that Deutsche Bank raised its price target for GMAB to DKK 2,400 from DKK 2,000 and reiterated a Buy rating, reflecting analysts' optimism [Read more]